Jun Miki, Wataru Fukuokaya, Rikiya Taoka, Ryoichi Saito, Yoshiyuki Matsui, Shingo Hatakeyama, Takashi Kawahara, Ayumu Matsuda, Taketo Kawai, Minoru Kato, et al. Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study. International journal of urology : official journal of the Japanese Urological Association. 2024
Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, et al. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association. 2024. 31. 5. 526-533
Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada, Junryo Rii, Sanji Kanaoka, Jiaxing Wei, Xue Zhao, Sangjon Pae, et al. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism. Cancer science. 2024
Ayumu Matsuda, Rikiya Taoka, Jun Miki, Ryoichi Saito, Wataru Fukuokaya, Shingo Hatakeyama, Takashi Kawahara, Yoichi Fujii, Minoru Kato, Tomokazu Sazuka, et al. Prognostic impact of histological discordance between transurethral resection and radical cystectomy. BJU international. 2024
Shinichi Sakamoto, Keisuke Ando, Sangjon Pae, Xue Zhao, Kazuko Sakai, Kodai Sato, Shinpei Saito, Yasutaka Yamada, Junryo Rii, Yusuke Goto, et al. Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer. Anticancer research. 2024. 44. 2. 639-647